Share on Social Media:
Company (headquarters) |
Global Sales | Percent Change | R&D Spending | Best Selling Drug 2008 | |
---|---|---|---|---|---|
1 | Pfizer (New York, USA) |
$44.2 billion | - 0.5% | $7.9 billion | Lipitor ($12.4 billion) |
2 | GlaxoSmithKline (Brentford, England) |
$43.0 billion | 11.2% | $5.2 billion | Seretide/Advair ($6.0 billion) |
3 | Sanofi-Aventis (Paris, France) |
$38.7 billion | 4.8% | $6.5 billion | Lovenox ($3.9 billion) |
4 | Novartis (Basel, Switzerland) |
$36.0 billion | 10.7% | $7.2 billion | Diovan/Co-Diovan ($5.7 billion) |
5 | AstraZeneca (London, England) |
$31.6 billion | 10.1% | $5.1 billion | Nexium ($5.2 billion) |